SOPHiA GENETICS (SOPH) CMO pre-planned sale of 608 shares for tax

Rhea-AI Filing Summary

SOPHiA GENETICS SA’s Chief Medical Officer, Philippe Menu, sold 608 Ordinary Shares of the company on May 19, 2026 at a weighted average price of $4.6059 per share. According to the disclosure, these shares were sold in the open market solely to satisfy tax withholding obligations arising from restricted stock units that vested on May 18, 2026. The transactions were executed under a pre-established Rule 10b5-1(c) trading plan, meaning they were pre-planned and not discretionary. Following this sale, Menu directly holds 255,780 Ordinary Shares.

Insider Trade Summary 10b5-1

Net Seller: 608 shares ($2,800)

Net Sell 1 txn

Insider Menu Philippe

Role Chief Medical Officer

Sold 608 shs ($3K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	608	$4.6059	$3K

Holdings After Transaction: Ordinary Shares — 255,780 shares (Direct, null)

Footnotes (1)

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 608 shares Weighted average sale price: $4.6059 per share Post-transaction holdings: 255,780 shares +1 more

4 metrics

Shares sold 608 shares Ordinary Shares sold on May 19, 2026

Weighted average sale price $4.6059 per share Open-market sales on May 19, 2026

Post-transaction holdings 255,780 shares Ordinary Shares directly held after sale

Sale price range $4.54–$4.66 per share Prices for multiple transactions included in the sale

Key Terms

restricted stock units, Rule 10b5-1(c) trading plan, weighted average price, tax withholding obligations

4 terms

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1(c) trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

weighted average price financial

"The price reported in Column 4 is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

tax withholding obligations financial

"sold by the Reporting Person in the open market to satisfy tax withholding obligations"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Menu Philippe

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/19/2026		S		608(1)	D	$4.6059(2)	255,780	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did SOPHiA GENETICS (SOPH) executive Philippe Menu report in this Form 4?

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS, reported selling 608 Ordinary Shares. The sale was tied to tax withholding for recently vested restricted stock units and executed under a pre-established Rule 10b5-1(c) trading plan, indicating it was not a discretionary trade.

How many SOPHiA GENETICS (SOPH) shares did Philippe Menu sell and at what price?

Philippe Menu sold 608 Ordinary Shares of SOPHiA GENETICS at a weighted average price of $4.6059 per share. The filing notes multiple trades within a price range from $4.54 to $4.66, and offers to provide detailed breakdowns upon written request.

Why did SOPHiA GENETICS (SOPH) executive Philippe Menu sell 608 shares?

The 608 shares were sold to satisfy tax withholding obligations related to the vesting of restricted stock units on May 18, 2026. The filing specifies these sales were made for tax purposes rather than discretionary portfolio changes, under a pre-established Rule 10b5-1(c) trading plan.

How many SOPHiA GENETICS (SOPH) shares does Philippe Menu hold after this transaction?

After the reported sale, Philippe Menu directly holds 255,780 Ordinary Shares of SOPHiA GENETICS. This post-transaction holding figure helps show that the 608-share sale was small relative to his total direct ownership position as disclosed in the filing.

Were Philippe Menu’s SOPHiA GENETICS (SOPH) share sales discretionary trades?

The filing states these sales were executed under a pre-established Rule 10b5-1(c) trading plan and were made to cover tax withholding obligations. This means the timing was pre-planned and the trades are not characterized as discretionary investment decisions by the executive.

What price range is disclosed for Philippe Menu’s SOPHiA GENETICS (SOPH) share sales?

The filing reports a weighted average sale price of $4.6059 per share, with individual transactions occurring between $4.54 and $4.66. It also states that detailed information on the number of shares sold at each separate price is available upon written request.